Julie Norville

Julie Norville is a highly accomplished professional with a strong educational background in Electrical Engineering and Bioengineering. She holds a PhD in EECS with a focus on bioengineering from the Massachusetts Institute of Technology, where her dissertation was advised by prominent figures like Tom Knight, Angela Belcher, and Gerald Sussman. Julie also earned an M.S. in EECS specializing in Bioengineering from MIT under the guidance of Tom Knight and Angela Belcher. Her academic journey includes a B.S. in Electrical Engineering from Caltech, showcasing her dedication to academic excellence. Additionally, she has affiliations with prestigious institutions like Harvard University and Lubbock High School.

Throughout her career, Julie Norville has been associated with a range of impactful organizations that reflect her expertise and leadership in the field. She has been involved in building a new startup focused on safer ways to cure diseases, displaying her commitment to innovation and healthcare advancement. Julie has also served as a Venture Partner at Axial, highlighting her strategic insights and business acumen. Her role as the Founder, CSO/CTO, and Board Member at JURA Bio, Inc., along with her previous position as a Research Fellow in Genetics at Harvard Medical School under the mentorship of George Church, underscores her profound contributions to the biotechnology and genetics sectors.